Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.835 USD | +11.89% | +18.57% | -39.53% |
Apr. 11 | Ocuphire Pharma Enrolls 1st Patient in Phase 3 Trial of Visual Acuity Treatment | MT |
Apr. 11 | Ocuphire Pharma, Inc. Announces Global License Agreement with Viatris Inc | CI |
- Stock Market
- Equities
- OCUP Stock
- News Ocuphire Pharma, Inc.
- Trading Ideas